Applications are invited for a clinical research fellow (CRF) for 24 months as 0.8 whole time equivalent position at ST4+ onwards to support the local recruitment of babies with moderate-severe hypoxic ischaemic encephalopathy (HIE) to a Phase I neonatal neuroprotection trial.
The ACUMEN Study is an international, multicentre Phase I, non-randomised dose escalation neonatal trial funded by the Medical Research Council (MRC). The Primary objectives are:
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.